scholarly article | Q13442814 |
P50 | author | Ralph Weissleder | Q7288259 |
Kamila Naxerova | Q55069868 | ||
Maarten Hulsmans | Q55363050 | ||
Filip K Swirski | Q60190510 | ||
Michael T Osborne | Q61112274 | ||
Michael R Zile | Q78851222 | ||
María Valero-Muñoz | Q83428089 | ||
Matthias Nahrendorf | Q88985829 | ||
Jason D Roh | Q92177801 | ||
Anthony Rosenzweig | Q92177817 | ||
David E Sosnovik | Q92797723 | ||
Yoshiko Iwamoto | Q93070371 | ||
Hendrik B Sager | Q114334709 | ||
Ahmed Tawakol | Q114418292 | ||
Benoit Tricot | Q114418302 | ||
Ronglih Liao | Q114418305 | ||
Flora Sam | Q38324772 | ||
Claudio Vinegoni | Q42728562 | ||
Gregory Wojtkiewicz | Q47151952 | ||
P2093 | author name string | Yuan Sun | |
Richard M Wilson | |||
Amy D Bradshaw | |||
Judy Hung | |||
Nicholas E Houstis | |||
P2860 | cites work | Interleukin-10 and the interleukin-10 receptor | Q24290912 |
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation | Q26850196 | ||
Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies | Q27000263 | ||
Imaging and nanomedicine in inflammatory atherosclerosis | Q27002916 | ||
Late Na(+) current and protracted electrical recovery are critical determinants of the aging myopathy | Q27318671 | ||
Trends in prevalence and outcome of heart failure with preserved ejection fraction | Q28252937 | ||
Age-related clonal hematopoiesis associated with adverse outcomes | Q28386602 | ||
A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
Protective and pathogenic functions of macrophage subsets | Q29620351 | ||
Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion | Q33777928 | ||
Age-related changes in tissue macrophages precede cardiac functional impairment | Q33801206 | ||
Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. | Q33847959 | ||
HFSA 2010 Comprehensive Heart Failure Practice Guideline | Q34124756 | ||
Cardioprotection and lifespan extension by the natural polyamine spermidine. | Q34544613 | ||
Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis | Q34646876 | ||
New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis | Q34720147 | ||
Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin | Q35328760 | ||
Protective Role of Interleukin-10 in Atherosclerosis | Q58150380 | ||
??? | Q28275770 | ||
Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study | Q35705092 | ||
Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence. | Q35837349 | ||
Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue | Q35882942 | ||
Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. | Q35893327 | ||
Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB | Q36174897 | ||
Redox-dependent protein kinase regulation by angiotensin II: mechanistic insights and its pathophysiology | Q36237592 | ||
Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. | Q36393927 | ||
Revisiting Cardiac Cellular Composition | Q36552350 | ||
Monocyte and macrophage contributions to cardiac remodeling. | Q36840151 | ||
Alternatively activated macrophages determine repair of the infarcted adult murine heart | Q36951782 | ||
The pathogenesis of cardiac fibrosis. | Q37161329 | ||
Clinical significance of diffusely increased splenic uptake on FDG-PET. | Q37572350 | ||
Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation | Q37581780 | ||
Neurohormonal control of heart failure | Q37942552 | ||
The immunology of fibrosis | Q38091697 | ||
Role of inflammatory cells in fibroblast activation | Q38643076 | ||
Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. | Q39061766 | ||
Fibroblast-to-myofibroblast switch is mediated by NAD(P)H oxidase generated reactive oxygen species. | Q39129812 | ||
Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells | Q39948728 | ||
Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association | Q40061255 | ||
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology | Q40224176 | ||
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. | Q41728608 | ||
T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation | Q42971196 | ||
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. | Q46750133 | ||
Osteopontin expression is required for myofibroblast differentiation | Q46850865 | ||
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study | Q48952305 | ||
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging | Q49060993 | ||
Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. | Q50545301 | ||
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. | Q50648250 | ||
Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. | Q50759304 | ||
Macrophages Facilitate Electrical Conduction in the Heart. | Q51041551 | ||
Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. | Q52900479 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | diastole | Q492905 |
Diastolic function | Q30314111 | ||
P304 | page(s) | 423-440 | |
P577 | publication date | 2018-01-16 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Cardiac macrophages promote diastolic dysfunction | |
P478 | volume | 215 |
Q92525212 | A Light Wand to Untangle the Myocardial Cell Network |
Q90668227 | A Miniaturized, Programmable Pacemaker for Long-Term Studies in the Mouse |
Q64259095 | Aging and GATA3-positive macrophages |
Q61420974 | Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling |
Q64091759 | Bioengineering adult human heart tissue: How close are we? |
Q90701028 | Biology and therapeutic potential of interleukin-10 |
Q90550496 | CD133+Exosome Treatment Improves Cardiac Function after Stroke in Type 2 Diabetic Mice |
Q91519556 | Cardioimmunology: the immune system in cardiac homeostasis and disease |
Q92813722 | Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding |
Q91547414 | Cellular cross-talks in the diseased and aging heart |
Q57293272 | Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials |
Q92715840 | Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales |
Q92132384 | Heart failure with preserved ejection fraction: present status and future directions |
Q87919221 | Heart failure: Macrophages promote cardiac fibrosis and diastolic dysfunction |
Q57772657 | Hypertension: a new treatment for an old disease? Targeting the immune system |
Q92810672 | Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy |
Q67405024 | Immune mechanisms of hypertension. |
Q90667609 | Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling |
Q97436071 | Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation |
Q49953935 | Interleukin-10 stiffens the heart. |
Q90356556 | Intermediate filaments in cardiomyopathy |
Q92817306 | Intramuscular Ricin Poisoning of Mice Leads to Widespread Damage in the Heart, Spleen, and Bone Marrow |
Q89965630 | Intravital Microscopy of the Beating Murine Heart to Understand Cardiac Leukocyte Dynamics |
Q95338244 | Leucocyte count predicts cardiovascular risk in heart failure with preserved ejection fraction: insights from TOPCAT Americas |
Q93165013 | Leukocyte-Dependent Regulation of Cardiac Fibrosis |
Q58606851 | Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodeling in a rat model of heart failure with preserved ejection fraction |
Q63915886 | Macrophages and Cardiovascular Health |
Q89753140 | Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction |
Q59327153 | Mesenchymal Stem Cell Therapy for Aging Frailty |
Q91433898 | Modulation of the monocyte/macrophage system in heart failure by targeting heme oxygenase-1 |
Q88985831 | Myeloid cell contributions to cardiovascular health and disease |
Q90751629 | Myeloid cells in cardiovascular organs |
Q52619556 | Myocardial Infarction Remodeling that Progresses to Heart Failure: A Signaling Misunderstanding. |
Q92592930 | Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses |
Q90261847 | Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation |
Q92094927 | Platelet-derived β2m regulates age related monocyte/macrophage functions |
Q91666914 | Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts |
Q91867387 | Qishen Granule Improved Cardiac Remodeling via Balancing M1 and M2 Macrophages |
Q90588213 | Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary |
Q90358735 | Role of Inflammatory Cell Subtypes in Heart Failure |
Q92234317 | Splenic Ly6Chi monocytes are critical players in dystrophic muscle injury and repair |
Q104455672 | SupErbB monocytes? Innate immune cells help the heart adapt |
Q101470159 | THE EFFECT OF MACROPHAGE-TARGETED INTERVENTIONS ON BLOOD PRESSURE - A SYSTEMATIC REVIEW AND META-ANALYSIS OF PRECLINICAL STUDIES |
Q90514877 | Temporal patterns of macrophage- and neutrophil-related markers are associated with clinical outcome in heart failure patients |
Q90652911 | The Role of Macrophages in Nonischemic Heart Failure |
Q89966619 | The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis |
Q64084317 | Three in a Box: Understanding Cardiomyocyte, Fibroblast, and Innate Immune Cell Interactions to Orchestrate Cardiac Repair Processes |
Q90143156 | White Blood Cells and Blood Pressure: A Mendelian Randomization Study |
Search more.